Skip to main content
. 2010 Sep 20;285(49):38234–38242. doi: 10.1074/jbc.M110.158626

TABLE 2.

Good substrates of CPA6

Protein name Peptide name Sequence Za T Obs M Theor M ppm Ratio, CPA6/no enzyme
Low CPA6 Med CPA6 High CPA6
Chromogranin B 600–613 QYDGVAELDQLLHY 2 1 1662.80 1662.79 4 1.03 0.69 0.00
Chromogranin B 64–86 SGKEVKGEEKGENQNSKFEVRLL 6 5 2604.38 2604.35 11 0.76 0.33 0.00
Proenkephalin Leu-Enkephalin YGGFL 1 1 555.27 555.27 −7 1.10 0.75 0.11
Proenkephalin Met-Enkephalin YGGFM 1 1 573.23 573.23 0 0.81 0.52 0.06
Proenkephalin Heptapeptide YGGFMRF 2 1 876.37 876.39 −25 0.73 0.00 0.00
Proenkephalin Octapeptide YGGFMRSL 2 1 929.43 929.45 −23 0.95 0.48 0.00
Pro-SAAS Little SAAS SLSAASAPLVETSTPLRL 2 1 1811.99 1812.01 −12 0.95 0.41 0.08
Secretogranin II 300–316 ESKDQLSEDASKVITYL 3 3 1924.94 1924.96 −11 0.79 0.42 0.00

a Z, charge; T, number of TMAB tags; Obs M, observed mass; Theor M, theoretical mass; ppm, difference in parts per million between observed mass and theoretical mass; ratio indicates the peak intensity observed for peptide incubated with CPA6 divided by the peak intensity for the same peptide incubated without enzyme.